Spots Global Cancer Trial Database for capecitabine
Every month we try and update this database with for capecitabine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Neoadjuvant Treatment for Advanced Rectal Carcinoma | NCT02551237 | Rectal Carcinom... | 50 Gy Capecitabine 25 Gy | 75 Years - | UNICANCER | |
| FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer | NCT02485834 | Adenocarcinoma ... Gastric Adenoca... Gastric Cancer | FDG-PET surgery 5-FU capecitabine docetaxel Irinotecan 3D-CRT IMRT | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Capecitabine For Nasopharyngeal Cancer | NCT00095901 | Head and Neck C... | Capecitabine | 18 Years - | Dana-Farber Cancer Institute | |
| A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors | NCT06139211 | Advanced Solid ... | JS015 Toripalimab Paclitaxel Irinotecan Capecitabine Oxaliplatin Bevacizumab Fluorouracil Leucovorin Gemcitabine Albumin-Bound P... | 18 Years - 75 Years | Shanghai Junshi Bioscience Co., Ltd. | |
| Safety, Tolerability and Pharmacokinetics of Oral Tablet of Irinotecan in Adult Patients With Solid Tumors | NCT03295084 | Metastatic Colo... | Irinotecan Capecitabine | 18 Years - | Herlev Hospital | |
| Phase II Trial for Large ER-Negative Breast Cancers | NCT01869192 | Malignant Neopl... | Epirubicin Cyclophosphamid... Docetaxel Capecitabine Radiation Thera... | 18 Years - | University of Colorado, Denver | |
| Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder | NCT00084942 | Extrahepatic Bi... Gallbladder Can... | capecitabine gemcitabine hyd... | 18 Years - | Roswell Park Cancer Institute | |
| Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)-China Extension | NCT04882241 | Gastric Cancer Gastroesophagea... | Pembrolizumab Placebo Cisplatin Capecitabine 5-fluorouracil Docetaxel Oxaliplatin Leucovorin | 18 Years - | Merck Sharp & Dohme LLC | |
| Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer | NCT03204734 | Breast Cancer | Capecitabine endocrine thera... | 18 Years - 70 Years | Zhejiang Cancer Hospital | |
| Multicenter, Prospective, RCT：Investigation of Combined Modality Therapy for Locally Advanced Mid/Low Rectal Cancer. | NCT03042000 | Rectal Cancer, ... Neoadjuvant Che... | non-NCRT NCRT capecitabine wi... capecitabine TEM radical resecti... | 18 Years - 75 Years | Peking Union Medical College Hospital | |
| Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction | NCT01015339 | Advanced Gastri... | Paclitaxel capecitabine capecitabine cisplatin | 18 Years - | Peking University | |
| XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based Chemotherapy | NCT02350686 | Biliary Tract C... | capecitabine oxaliplatin | 18 Years - | Samsung Medical Center | |
| Short-course Radiotherapy Based TNT Combined With PD-1 Inhibitor for Locally Advanced Rectal Cancer | NCT04518280 | Locally Advance... | PD-1 antibody Capecitabine Oxaliplatin Short-course ra... | 18 Years - 70 Years | Fudan University | |
| Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer | NCT02954536 | Esophageal Canc... Gastric Cancer | pembrolizumab trastuzumab capecitabine cisplatin Oxaliplatin 5-Fluorouracil | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma | NCT00165217 | Colorectal Aden... | Capecitabine Thalidomide | 18 Years - | Dana-Farber Cancer Institute | |
| Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers | NCT00798252 | Advanced Cancer | Capecitabine Doxorubicin Ixabepilone Docetaxel Paclitaxel Brivanib alanin... | 18 Years - 75 Years | Bristol-Myers Squibb | |
| Biological-guided Metronomic Chemotherapy as Maintenance Strategy in Metastatic Colorectal Cancer | NCT03158610 | Colorectal Canc... | Capecitabine | 18 Years - 75 Years | Ruijin Hospital | |
| Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR | NCT06393374 | Triple-Negative... | Pembrolizumab sac-TMT Capecitabine | 18 Years - | Merck Sharp & Dohme LLC | |
| Total Neoadjuvant Therapy of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer (ENSEMBLE) | NCT05646511 | Locally Advance... | SCRT CAPOX CAPOXIRI | 18 Years - | National Cancer Center Hospital East | |
| Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer | NCT05239169 | Biliary Tract C... Intrahepatic Ch... Hilar Cholangio... Distal Cholangi... Gall Bladder Ca... | Durvalumab Tremelimumab Capecitabine | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer | NCT00640081 | Colorectal Canc... | cetuximab capecitabine fluorouracil leucovorin calc... oxaliplatin immunohistochem... laboratory biom... | 18 Years - 100 Years | Medical Research Council | |
| Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer | NCT00613080 | Colorectal Canc... | capecitabine oxaliplatin resection radiation thera... FOLFOX | 18 Years - | Radiation Therapy Oncology Group | |
| Postoperative Chemoradiation or Chemotherapy After Preoperative Chemotherapy for Gastric Cancers | NCT03515941 | Gastrointestina... | Oxaliplatin Capecitabine Leucovorin 5-fluorouracil radiation | 18 Years - | Baylor College of Medicine | |
| A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients | NCT02854072 | Pancreatic Canc... | GV1001 Gemcitabine Capecitabine | 19 Years - | Samsung Pharmaceutical Co., Ltd. | |
| Total Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on Neoantigen | NCT04340401 | Rectal Cancer | SHR-1210 Oxaliplatin Capecitabine Intensity modul... Total mesorecta... | 18 Years - 70 Years | Peking University Cancer Hospital & Institute | |
| Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer | NCT04703101 | Locally Advance... Rectal Adenocar... Stage II Rectal... Stage IIA Recta... Stage IIB Recta... Stage IIC Recta... Stage III Recta... Stage IIIA Rect... Stage IIIB Rect... Stage IIIC Rect... | Capecitabine Fluorouracil Intensity-Modul... Leucovorin Oxaliplatin Quality-of-Life... Surveillance Total Mesorecta... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers | NCT00626158 | Pancreatic Canc... Biliary Cancer | gemcitabine capecitabine | 18 Years - | University of California, San Francisco | |
| Trial of Vinflunine Plus Capecitabine in Advanced Breast Cancer | NCT01095003 | Breast Cancer | Vinflunine plus... Capecitabine | 21 Years - | Pierre Fabre Medicament | |
| Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer | NCT00062426 | Colorectal Canc... | bevacizumab capecitabine fluorouracil leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| Efficacy and Safety Evaluation of Sintilimab or Placebo in Combination With XELOX as First Line Treatment in Patients With Gastric Cancer | NCT03745170 | Gastric Cancer | Sintilimab Oxaliplatin Capecitabine placebo | 18 Years - | Innovent Biologics (Suzhou) Co. Ltd. | |
| Association of Genetic Polymorphisms With Capecitabine-based Chemotherapy Toxicities in Chinese Solid Tumor Patients | NCT03258099 | Solid Tumor Capecitabine Drug-Related Si... Pharmacogenetic... Pharmacokinetic... | detection of ge... | 18 Years - | Peking University First Hospital | |
| A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases | NCT03500380 | Breast Neoplasm... Breast Diseases Capecitabine HER2-positive B... HER2 Positive B... HER2-positive A... | RC48-ADC Lapatinib Capecitabine | 18 Years - 70 Years | RemeGen Co., Ltd. | |
| Immunoscore as Decision Guidance for Adjuvant Chemotherapy in Colon Cancer | NCT04488159 | Colon Cancer St... | Capecitabine Oxaliplatin Fluorouracil Leucovorin Immunoscore® as... Physical exerci... | 18 Years - 100 Years | Medical University of Vienna | |
| PD-1 Inhibitor Sintilimab Combined With Capecitabine for Adjuvant Treatment After Radical Resection of Cholangiocarcinoma. | NCT05207735 | Cholangiocarcin... | Sintilimab | 18 Years - 75 Years | Henan Cancer Hospital | |
| Rectal Preserving Treatment for Early Rectal Cancer. A Multi-centred Randomised Trial of Radical Surgery Versus Adjuvant Chemoradiotherapy After Local Excision for Early Rectal Cancers | NCT02371304 | Rectal Cancer | Adjuvant chemor... Additional TME ... capecitabine | 18 Years - | Amsterdam UMC, location VUmc | |
| Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor | NCT00005839 | Unspecified Adu... | capecitabine oxaliplatin | 18 Years - | City of Hope Medical Center | |
| HKI-272 for HER2-Positive Breast Cancer and Brain Metastases | NCT01494662 | Breast Cancer | HKI-272 Surgical Resect... Capecitabine HKI-272 Ado-Trastuzumab... | 18 Years - | Dana-Farber Cancer Institute | |
| Immunoscore as Decision Guidance for Adjuvant Chemotherapy in Colon Cancer | NCT04488159 | Colon Cancer St... | Capecitabine Oxaliplatin Fluorouracil Leucovorin Immunoscore® as... Physical exerci... | 18 Years - 100 Years | Medical University of Vienna | |
| Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the Breast | NCT01204437 | Breast Cancer | Epirubicin, Cyc... Cyclophosphamid... Capecitabine, N... | 65 Years - | German Breast Group | |
| Neoadjuvant Chemoradiotherapy Combined With Tislelizumab in the Treatment of Locally Advanced Rectal Cancer | NCT05479240 | Immunotherapy | Tislelizumab Capecitabine oxaliplatin short-range rad... | 18 Years - 75 Years | Fujian Cancer Hospital | |
| Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer | NCT00365417 | Breast Cancer | Bevacizumab Doxorubicin Cyclophosphamid... Capecitabine Docetaxel | 18 Years - | NSABP Foundation Inc | |
| A Study of Ruxolitinib in Combination With Capecitabine in Subjects With Advanced or Metastatic HER2-negative Breast Cancer | NCT02120417 | Breast Cancer | Ruxolitinib Capecitabine Placebo | 18 Years - | Incyte Corporation | |
| Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers | NCT00848783 | Gastric Cancer Gastric Adenoca... Esophageal Canc... | Irinotecan Cisplatin Surgery Floxuridine Capecitabine | 18 Years - | NYU Langone Health | |
| Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients | NCT03921684 | Rectal Cancer | Capecitabine Radiation thera... mFOLFOX6 Nivolumab | 18 Years - | Rabin Medical Center | |
| Study of Aflibercept as Maintenance Therapy Following Induction With Aflibercept in Combination With XELOX, as First-Line Treatment for Metastatic Colorectal Cancer Patient | NCT01955629 | Colorectal Canc... | Aflibercept AVE... Oxaliplatin Capecitabine | 18 Years - | Sanofi | |
| Clinical Control Study of Immunotherapy and Concurrent Chemoradiotherapy in Patients With Esophageal Cancer Recurrence | NCT04404491 | Esophageal Mali... | Procedural deat... Capecitabine Radiotherapy Placebo | 18 Years - 75 Years | The First Affiliated Hospital of Henan University of Science and Technology | |
| A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors | NCT02715531 | Solid Tumor | 5-FU Atezolizumab Bevacizumab Gemcitabine Leucovorin Nab-Paclitaxel Oxaliplatin Capecitabine Cisplatin | 18 Years - | Hoffmann-La Roche | |
| Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal Cancer | NCT00084591 | Colorectal Canc... | capecitabine conventional su... neoadjuvant the... radiation thera... | 18 Years - | Fox Chase Cancer Center | |
| Capecitabine For Nasopharyngeal Cancer | NCT00095901 | Head and Neck C... | Capecitabine | 18 Years - | Dana-Farber Cancer Institute | |
| Immunotherapy In Locally Advanced Rectal Cancer | NCT03854799 | Colon Rectal Ca... | Avelumab Capecitabine EXTERNAL---BEAM... | 18 Years - | Gruppo Oncologico del Nord-Ovest | |
| An Observational Study of Adjuvant Treatment With Capecitabine (Xeloda) in Combination With Oxaliplatin in Participants With Stage III Colon Cancer | NCT01442155 | Colorectal Canc... | Capecitabine Oxaliplatin | 18 Years - | Hoffmann-La Roche | |
| The Therapeutic Effect of Different Doses of Capecitabine | NCT06246461 | Capecitabine | capecitabine | 40 Years - 69 Years | Jingjiang People's Hospital | |
| microRNA of Human Epidermal Growth Factor Receptor 2 （HER2）Positive Patient Treated With Herceptin | NCT02656589 | Breast Cancer | Capecitabine Trastuzumab | 18 Years - | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Gefitinib and Capecitabine in Treating Patients With Advanced Solid Tumors | NCT00039390 | Unspecified Adu... | capecitabine gefitinib pharmacological... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma | NCT01161186 | Pancreatic Neop... Pancreatic Canc... Adenocarcinoma | nab-paclitaxel,... | 18 Years - | University of California, San Francisco | |
| Safety of a Boost (CXB or EBRT) in Combination With Neoadjuvant Chemoradiotherapy for Early Rectal Adenocarcinoma | NCT02505750 | Rectal Neoplasm... | 3D conformal EB... Contact X-ray b... Capecitabine | 18 Years - | Centre Antoine Lacassagne | |
| Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies | NCT00215501 | Solid Tumor | Capecitabine 5-Fluorouracil ... Irinotecan Cisplatin | 18 Years - | Dana-Farber Cancer Institute | |
| Phase III Palbociclib With Endocrine Therapy vs. Capecitabine in HR+/HER2- MBC With Resistance to Aromatase Inhibitors | NCT02028507 | Metastatic Brea... | Palbociclib Capecitabine Exemestane Fulvestrant | 18 Years - | Spanish Breast Cancer Research Group | |
| Association of Dihydropyrimidine Dehydrogenase (DPYD) Variants With Toxicity Related to Capecitabine | NCT00478686 | Breast Cancer | Phlebotomy | - | M.D. Anderson Cancer Center | |
| Effectiveness of Pharmacist Intervention on Capecitabine Relative Dose Intensity, Adherence, Knowledge & Safety Among Cancer Patients in Malaysia | NCT04175899 | Solid Tumor, Ad... | Pharmacist-led ... | 18 Years - | Ministry of Health, Malaysia | |
| Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery | NCT00305877 | Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... | cetuximab gemcitabine hyd... capecitabine radiation thera... bevacizumab laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Carcinoma | NCT03469557 | Esophageal Squa... | Tislelizumab Cisplatin 5-FU Oxaliplatin Capecitabine | 18 Years - 75 Years | BeiGene | |
| X Versus Placebo as Postoperative Adjuvant Treatment for Elder Breast Cancer | NCT02838238 | Breast Cancer | Capecitabine Placebo | 70 Years - | Peking Union Medical College Hospital | |
| Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer | NCT00614653 | Pancreatic Canc... | Bevacizumab Erlotinib Capecitabine Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies | NCT00215501 | Solid Tumor | Capecitabine 5-Fluorouracil ... Irinotecan Cisplatin | 18 Years - | Dana-Farber Cancer Institute | |
| Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers | NCT02720601 | Biliary Tract C... | Irinotecan & Ca... | 18 Years - | New Mexico Cancer Care Alliance | |
| A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer. | NCT00454636 | Gastric Cancer | Cisplatin Capecitabine Epirubicin Cisplatin Capecitabine Oxaliplatin Docetaxel Capecitabine | 18 Years - | Hoffmann-La Roche | |
| Metastatic Gastric Cancer FFCD 03-07 | NCT00374036 | Stomach Cancer Neoplasm Metast... | ECC FOLFIRI | 18 Years - | University Hospital, Toulouse | |
| The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer | NCT04185649 | HER2-positive A... | BAT8001 for inj... Lapatinib Capecitabine | 18 Years - 75 Years | Bio-Thera Solutions | |
| Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma | NCT05201859 | Nasopharyngeal ... | Sintilimab Capecitabine | 18 Years - 70 Years | Sun Yat-sen University | |
| A Study Of Neratinib (HKI-272) And Capecitabine In Japanese With Solid Tumor | NCT01128842 | Advanced Malign... | Neratinib Capecitabine | 20 Years - | Puma Biotechnology, Inc. | |
| A Study of Avastin (Bevacizumab) in Combination Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum | NCT01131078 | Colorectal Canc... | Bevacizumab [Av... Capecitabine Irinotecan | 18 Years - | Hoffmann-La Roche | |
| A Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma | NCT06118333 | Nasopharyngeal ... | BL-B01D1 capecitabine gemcitabine docetaxel | 18 Years - | Sichuan Baili Pharmaceutical Co., Ltd. | |
| Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer | NCT00482222 | Colorectal Canc... Metastatic Canc... | cetuximab capecitabine fluorouracil leucovorin calc... oxaliplatin study of socioe... adjuvant therap... neoadjuvant the... quality-of-life... | 18 Years - | University of Southampton | |
| Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD) | NCT04443348 | Triple Negative... Hormone Recepto... Biopsy-proven, ... | Radiation Thera... Pembrolizumab Paclitaxel Carboplatin Cyclophosphamid... Doxorubicin Capecitabine | 18 Years - | Massachusetts General Hospital | |
| Dendrobium Huoshanense Suppository in Rectal Cancer | NCT05079438 | Locally Advance... | Dendrobium Huos... | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
| Capecitabine in the Perioperative Treatment of Rectal Cancer | NCT01500993 | Rectal Cancer | Capecitabine 5-FU | 18 Years - | Universitätsmedizin Mannheim | |
| A Study of SKB264 Versus Investigator's Choice Chemotherapy in Patients With Unresectable Recurrent or Metastatic Triple-Negative Breast Cancer | NCT06279364 | Triple Negative... | SKB264 Paclitaxel Nab-paclitaxel Capecitabine Eribulin Carboplatin | 18 Years - 75 Years | Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. | |
| A Study of Capecitabine (Xeloda®) and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem Gliomas | NCT01118377 | Brainstem Gliom... | Capecitabine Radiation thera... | 3 Years - 17 Years | Hoffmann-La Roche | |
| Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma | NCT02935309 | Rectal Cancer Rectal Adenocar... | Lenvatinib Capecitabine External Radiat... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
